Phactr2 and Parkinson's disease

Christian Wider, Sarah J. Lincoln, Michael G. Heckman, Nancy N. Diehl, Jeremy T. Stone, Kristoffer Haugarvoll, Jan O. Aasly, J. Mark Gibson, Timothy Lynch, Alex Rajput, Michele L. Rajput, Ryan J. Uitti, Zbigniew K Wszolek, Matthew J. Farrer, Owen A Ross

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Attempts at replicating the first genome-wide association study (GWAS) in Parkinson's disease (PD) have not successfully identified genetic risk factors. The present study reevaluates data from the first GWAS and focuses on the SNP (rs11155313, located in the Phactr2 gene) with the lowest P-value in the Tier 2 patient-control series. We employed four case-control series to examine the nominated SNP rs11155313 and identified association in US (OR: 1.39, P = 0.032), Canadian (OR: 1.41, P = 0.014) and Irish (OR: 1.44, P = 0.034) patient-control series, but not in the Norwegian series (OR: 1.15, P = 0.27). When combining all four series the observed trend was statistically significant (OR: 1.30, P < 0.001). This study shows that reappraisal of publicly available results of GWAS may help nominate new risk factors for PD.

Original languageEnglish (US)
Pages (from-to)9-11
Number of pages3
JournalNeuroscience Letters
Volume453
Issue number1
DOIs
StatePublished - Mar 27 2009

Fingerprint

Genome-Wide Association Study
Parkinson Disease
Single Nucleotide Polymorphism
Genes

Keywords

  • Genome-wide association
  • Parkinson's disease
  • Phactr2

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Wider, C., Lincoln, S. J., Heckman, M. G., Diehl, N. N., Stone, J. T., Haugarvoll, K., ... Ross, O. A. (2009). Phactr2 and Parkinson's disease. Neuroscience Letters, 453(1), 9-11. https://doi.org/10.1016/j.neulet.2009.02.009

Phactr2 and Parkinson's disease. / Wider, Christian; Lincoln, Sarah J.; Heckman, Michael G.; Diehl, Nancy N.; Stone, Jeremy T.; Haugarvoll, Kristoffer; Aasly, Jan O.; Gibson, J. Mark; Lynch, Timothy; Rajput, Alex; Rajput, Michele L.; Uitti, Ryan J.; Wszolek, Zbigniew K; Farrer, Matthew J.; Ross, Owen A.

In: Neuroscience Letters, Vol. 453, No. 1, 27.03.2009, p. 9-11.

Research output: Contribution to journalArticle

Wider, C, Lincoln, SJ, Heckman, MG, Diehl, NN, Stone, JT, Haugarvoll, K, Aasly, JO, Gibson, JM, Lynch, T, Rajput, A, Rajput, ML, Uitti, RJ, Wszolek, ZK, Farrer, MJ & Ross, OA 2009, 'Phactr2 and Parkinson's disease', Neuroscience Letters, vol. 453, no. 1, pp. 9-11. https://doi.org/10.1016/j.neulet.2009.02.009
Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K et al. Phactr2 and Parkinson's disease. Neuroscience Letters. 2009 Mar 27;453(1):9-11. https://doi.org/10.1016/j.neulet.2009.02.009
Wider, Christian ; Lincoln, Sarah J. ; Heckman, Michael G. ; Diehl, Nancy N. ; Stone, Jeremy T. ; Haugarvoll, Kristoffer ; Aasly, Jan O. ; Gibson, J. Mark ; Lynch, Timothy ; Rajput, Alex ; Rajput, Michele L. ; Uitti, Ryan J. ; Wszolek, Zbigniew K ; Farrer, Matthew J. ; Ross, Owen A. / Phactr2 and Parkinson's disease. In: Neuroscience Letters. 2009 ; Vol. 453, No. 1. pp. 9-11.
@article{656ad32329f749fbb0219ef7951bfa96,
title = "Phactr2 and Parkinson's disease",
abstract = "Attempts at replicating the first genome-wide association study (GWAS) in Parkinson's disease (PD) have not successfully identified genetic risk factors. The present study reevaluates data from the first GWAS and focuses on the SNP (rs11155313, located in the Phactr2 gene) with the lowest P-value in the Tier 2 patient-control series. We employed four case-control series to examine the nominated SNP rs11155313 and identified association in US (OR: 1.39, P = 0.032), Canadian (OR: 1.41, P = 0.014) and Irish (OR: 1.44, P = 0.034) patient-control series, but not in the Norwegian series (OR: 1.15, P = 0.27). When combining all four series the observed trend was statistically significant (OR: 1.30, P < 0.001). This study shows that reappraisal of publicly available results of GWAS may help nominate new risk factors for PD.",
keywords = "Genome-wide association, Parkinson's disease, Phactr2",
author = "Christian Wider and Lincoln, {Sarah J.} and Heckman, {Michael G.} and Diehl, {Nancy N.} and Stone, {Jeremy T.} and Kristoffer Haugarvoll and Aasly, {Jan O.} and Gibson, {J. Mark} and Timothy Lynch and Alex Rajput and Rajput, {Michele L.} and Uitti, {Ryan J.} and Wszolek, {Zbigniew K} and Farrer, {Matthew J.} and Ross, {Owen A}",
year = "2009",
month = "3",
day = "27",
doi = "10.1016/j.neulet.2009.02.009",
language = "English (US)",
volume = "453",
pages = "9--11",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Phactr2 and Parkinson's disease

AU - Wider, Christian

AU - Lincoln, Sarah J.

AU - Heckman, Michael G.

AU - Diehl, Nancy N.

AU - Stone, Jeremy T.

AU - Haugarvoll, Kristoffer

AU - Aasly, Jan O.

AU - Gibson, J. Mark

AU - Lynch, Timothy

AU - Rajput, Alex

AU - Rajput, Michele L.

AU - Uitti, Ryan J.

AU - Wszolek, Zbigniew K

AU - Farrer, Matthew J.

AU - Ross, Owen A

PY - 2009/3/27

Y1 - 2009/3/27

N2 - Attempts at replicating the first genome-wide association study (GWAS) in Parkinson's disease (PD) have not successfully identified genetic risk factors. The present study reevaluates data from the first GWAS and focuses on the SNP (rs11155313, located in the Phactr2 gene) with the lowest P-value in the Tier 2 patient-control series. We employed four case-control series to examine the nominated SNP rs11155313 and identified association in US (OR: 1.39, P = 0.032), Canadian (OR: 1.41, P = 0.014) and Irish (OR: 1.44, P = 0.034) patient-control series, but not in the Norwegian series (OR: 1.15, P = 0.27). When combining all four series the observed trend was statistically significant (OR: 1.30, P < 0.001). This study shows that reappraisal of publicly available results of GWAS may help nominate new risk factors for PD.

AB - Attempts at replicating the first genome-wide association study (GWAS) in Parkinson's disease (PD) have not successfully identified genetic risk factors. The present study reevaluates data from the first GWAS and focuses on the SNP (rs11155313, located in the Phactr2 gene) with the lowest P-value in the Tier 2 patient-control series. We employed four case-control series to examine the nominated SNP rs11155313 and identified association in US (OR: 1.39, P = 0.032), Canadian (OR: 1.41, P = 0.014) and Irish (OR: 1.44, P = 0.034) patient-control series, but not in the Norwegian series (OR: 1.15, P = 0.27). When combining all four series the observed trend was statistically significant (OR: 1.30, P < 0.001). This study shows that reappraisal of publicly available results of GWAS may help nominate new risk factors for PD.

KW - Genome-wide association

KW - Parkinson's disease

KW - Phactr2

UR - http://www.scopus.com/inward/record.url?scp=60949108166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60949108166&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2009.02.009

DO - 10.1016/j.neulet.2009.02.009

M3 - Article

VL - 453

SP - 9

EP - 11

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -